RecruitingNot ApplicableNCT06974279

Post-Stroke Aphasia TMS

Precision Neuromodulation in Post-Stroke Aphasia Using TMS


Sponsor

Medical College of Wisconsin

Enrollment

50 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Control TMS with SFA and a medical device called Precision TMS with SFA for people with aphasia, language, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPrecision TMS with SFA

Excitatory TMS delivered using a precision site finding approach and intermittent theta burst stimulation protocol

DEVICEControl TMS with SFA

Excitatory TMS using intermittent theta burst stimulation delivered to a control vertex site.


Locations(1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06974279


Related Trials